r.rotation.to⌕ Search stocks, people, sectors
Following this device: dark.
Request a free account

Follow the people · Insider

NS

Nelson Sun

Insider · Officer · AARD

Nelson Sun files insider transactions with the SEC as an officer of Aardvark Therapeutics. We hold 2 disclosed purchases and sales filed since 19 February 2025, 2 of them in the last 90 days.

  • Files forAARD
  • Disclosed buys and sells2 in all, 2 in the last 90 days
  • Last disclosure11 September 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 14 February 2025 — 11 September 2026Officer · Aardvark Therapeutics 10 Form 4 lines · source: SEC Form 4

Every transaction

10 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing
10 of 10 shown
11 Sep 202611 Sep 2026SEC Form 40 dsold on the open marketAardvark Therapeutics62,000 sharesup +0.0%up +0.0%
10 Sep 202611 Sep 2026SEC Form 41 dsold on the open marketAardvark Therapeutics14,754 sharesup +2.4%up +0.0%
9 Feb 202611 Feb 2026SEC Form 42 dwas grantednot a tradeAardvark Therapeuticsderivative70,549 sharesdown −61.9%down −59.5%
9 Feb 202611 Feb 2026SEC Form 42 dwas grantednot a tradeAardvark Therapeuticsderivative70,549 sharesdown −61.9%down −59.5%
11 Dec 202512 Dec 2025SEC Form 41 dbought on the open marketAardvark Therapeutics3,000 sharesdown −67.1%down −64.4%
9 Sep 202510 Sep 2025SEC Form 41 dbought on the open marketAardvark Therapeutics6,000 sharesdown −35.1%down −35.9%
11 Jun 202513 Jun 2025SEC Form 42 dwas grantednot a tradeAardvark Therapeuticsderivative209,826 sharesdown −54.6%down −52.2%
14 Feb 202519 Feb 2025SEC Form 45 dconvertednot a tradeAardvark Therapeuticsderivative59,332 sharesdown −61.4%down −65.6%
14 Feb 202519 Feb 2025SEC Form 45 dconvertednot a tradeAardvark Therapeutics7,001 sharesdown −61.4%down −65.6%
14 Feb 202519 Feb 2025SEC Form 45 dbought on the open marketAardvark Therapeutics10,000 sharesdown −61.4%down −65.6%

Both percentages are the stock’s move, not Nelson Sun’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 10 of the 10 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.